RIL
PRME icon

Rothschild Investment LLC’s Prime Medicine PRME Stock Holding History

Rothschild Investment LLC’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.42K Buy
384
+2
+0.5% +$7 ﹤0.01% 2901
2026
Q1 		$1.33K Buy
382
+37
+11% +$141 ﹤0.01% 2747
2025
Q4 		$1.2K Hold
345
– – ﹤0.01% 2607
2025
Q3 		$1.91K Hold
345
– – ﹤0.01% 2258
2025
Q2 		$852 Buy
345
+30
+10% +$46 ﹤0.01% 2551
2025
Q1 		$627 Buy
315
+35
+13% +$89 ﹤0.01% 2545
2024
Q4 		$818 Buy
+280
New +$983 ﹤0.01% 2340

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
ACM
Alessandra Capital Management Torrance, California $141M AUM
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
IEFM
IQ EQ Fund Management Dublin 2, Ireland $1.57B AUM 40.42% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
KFGK
Keystone Financial Group (Kentucky) Lexington, Kentucky $1.69B AUM 40.17% 1-Year Est. Return

Rothschild Investment LLC's PRME Position: Q2 2026 in Review

Rothschild Investment LLC increased its Prime Medicine (PRME) stake by 0.52% in Q2 2026, buying an estimated $7 and bringing the position to 384 shares worth $1.42K. The position accounts for ﹤0.01% of the portfolio, ranked #2901.

Rothschild Investment LLC first reported a position in PRME in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.91K in Q3 2025. 63 funds tracked by Wall St. Rank hold PRME as of Q2 2026.

  • Rothschild Investment LLC held 384 shares of Prime Medicine worth $1.42K as of Q2 2026.
  • Rothschild Investment LLC bought 2 Prime Medicine shares in Q2 2026, an estimated $7.
  • Prime Medicine made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #2901 holding.
  • Rothschild Investment LLC first reported a position in Prime Medicine in Q4 2024 and has held it in 7 quarters since.
  • Rothschild Investment LLC's Prime Medicine position peaked at $1.91K in Q3 2025.
  • 63 funds tracked by Wall St. Rank held Prime Medicine as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.